<VariationArchive RecordType="classified" VariationID="1338782" VariationName="NM_004006.3:c.(1602+1_1603-1)_(6438+1_6439-1)del" VariationType="Deletion" Accession="VCV001338782" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2022-02-03" MostRecentSubmission="2022-02-03">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1329816" VariationID="1338782">
      <GeneList>
        <Gene Symbol="DMD" FullName="dystrophin" GeneID="1756" HGNC_ID="HGNC:2928" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>Xp21.2-21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="31119222" stop="33339388" display_start="31119222" display_stop="33339388" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="31137344" stop="33357725" display_start="31137344" display_stop="33357725" Strand="-" />
          </Location>
          <OMIM>300377</OMIM>
          <Haploinsufficiency last_evaluated="2019-11-20" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DMD">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-11-20" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DMD">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004006.3:c.(1602+1_1603-1)_(6438+1_6439-1)del</Name>
      <VariantType>Deletion</VariantType>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004006.3" sequenceAccession="NM_004006" sequenceVersion="3" change="c.(1602+1_1603-1)_(6438+1_6439-1)del" MANESelect="true">
            <Expression>NM_004006.3:c.(1602+1_1603-1)_(6438+1_6439-1)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004006.3:c.(1602+1_1603-1)_(6438+1_6439-1)del AND Becker muscular dystrophy" Accession="RCV001823016" Version="1">
        <ClassifiedConditionList TraitSetID="3096">
          <ClassifiedCondition DB="MedGen" ID="C0917713">Becker muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-01-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-01-06" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-02-03" MostRecentSubmission="2022-02-03">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3096" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3056" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Becker muscular dystrophy</ElementValue>
                <XRef ID="Becker+Muscular+Dystrophy/771" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010311" DB="MONDO" />
                <XRef ID="387732009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Benign pseudohypertrophic muscular dystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Becker's muscular dystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy pseudohypertrophic progressive, Becker type</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BMD</ElementValue>
                <XRef Type="MIM" ID="300376" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5900" />
                <XRef ID="5900" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The dystrophinopathies cover a spectrum of X-linked muscle disease ranging from mild to severe that includes Duchenne muscular dystrophy, Becker muscular dystrophy, and DMD-associated dilated cardiomyopathy (DCM). The mild end of the spectrum includes the phenotypes of asymptomatic increase in serum concentration of creatine phosphokinase (CK) and muscle cramps with myoglobinuria. The severe end of the spectrum includes progressive muscle diseases that are classified as Duchenne/Becker muscular dystrophy when skeletal muscle is primarily affected and as DMD-associated DCM when the heart is primarily affected. Duchenne muscular dystrophy (DMD) usually presents in early childhood with delayed motor milestones including delays in walking independently and standing up from a supine position. Proximal weakness causes a waddling gait and difficulty climbing stairs, running, jumping, and standing up from a squatting position. DMD is rapidly progressive, with affected children being wheelchair dependent by age 12 years. Cardiomyopathy occurs in almost all individuals with DMD after age 18 years. Few survive beyond the third decade, with respiratory complications and progressive cardiomyopathy being common causes of death. Becker muscular dystrophy (BMD) is characterized by later-onset skeletal muscle weakness. With improved diagnostic techniques, it has been recognized that the mild end of the spectrum includes men with onset of symptoms after age 30 years who remain ambulatory even into their 60s. Despite the milder skeletal muscle involvement, heart failure from DCM is a common cause of morbidity and the most common cause of death in BMD. Mean age of death is in the mid-40s. DMD-associated DCM is characterized by left ventricular dilation and congestive heart failure. Females heterozygous for a DMD pathogenic variant are at increased risk for DCM.</Attribute>
                <XRef ID="NBK1119" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="Position Statement" Abbrev="AAP, 2005">
                <ID Source="PubMed">16322188</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301298</ID>
                <ID Source="BookShelf">NBK1119</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="AAN, 2014">
                <ID Source="PubMed">25313375</ID>
                <ID Source="pmc">4206155</ID>
              </Citation>
              <XRef ID="98895" DB="Orphanet" />
              <XRef ID="C0917713" DB="MedGen" />
              <XRef ID="MONDO:0010311" DB="MONDO" />
              <XRef Type="MIM" ID="300376" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4061938" SubmissionDate="2022-01-31" DateLastUpdated="2022-02-03" DateCreated="2022-02-03">
        <ClinVarSubmissionID localKey="CVb_1306|OMIM:300376" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002072520" DateUpdated="2022-02-03" DateCreated="2022-02-03" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, University of Leipzig Medical Center" OrgID="506086" OrganizationCategory="clinic" OrgAbbreviation="UKL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant was identified as hemizygous._x000D_ Criteria applied: PVS1_STR, PS4, PM2_SUP</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DMD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004006.3:c.(1602+1_1603-1)_(6438+1_6439-1)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300376" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11018895</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4061938" TraitType="Disease" MappingType="XRef" MappingValue="300376" MappingRef="OMIM">
        <MedGen CUI="C0917713" Name="Becker muscular dystrophy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

